Decade Capital Management’s Amedisys AMED Stock Holding History

Decade Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$946K	Sell	24,915 -356,557	-93%	-$15M	0.2%	84
2015 Q2	$15.2M	Sell	381,472 -1,041	-0.3%	-$32.4K	1.83%	14
2015 Q1	$10.2M	Buy	382,513 +127,614	+50%	+$3.6M	1.27%	23
2014 Q4	$7.48M	Sell	254,899 -73,173	-22%	-$1.81M	1.28%	27
2014 Q3	$6.62M	Buy	+328,072	New	+$6.33M	0.78%	36

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Decade Capital Management's AMED Position: Q3 2015 in Review

Decade Capital Management reduced its Amedisys (AMED) stake by 93% in Q3 2015, selling an estimated $15M and leaving 24,915 shares worth $946K. The position accounts for 0.2% of the portfolio, ranked #84.

Decade Capital Management first reported a position in AMED in Q3 2014 and has held it in 5 quarters since. The position peaked at $15.2M in Q2 2015. 173 funds tracked by Wall St. Rank hold AMED as of Q3 2015.

Decade Capital Management held 24,915 shares of Amedisys worth $946K as of Q3 2015.
Decade Capital Management sold 356,557 Amedisys shares in Q3 2015, an estimated $15M.
Amedisys made up 0.2% of Decade Capital Management's portfolio in Q3 2015, its #84 holding.
Decade Capital Management first reported a position in Amedisys in Q3 2014 and has held it in 5 quarters since.
Decade Capital Management's Amedisys position peaked at $15.2M in Q2 2015.
173 funds tracked by Wall St. Rank held Amedisys as of Q3 2015.

Based on Decade Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.